A Clinical Trial to Evaluate the Effects of a Chickpea Pasta on Gut Health, Blood Glucose, and Overall Health

Banza LLC

Status

Completed

Conditions

Gut Health

Gastrointestinal Health

Treatments

Dietary Supplement: Chickpea Pasta

Study type

Interventional

Funder types

Industry

Identifiers

NCT07264465

20724 (Other Identifier)

Details and patient eligibility

About

This is a single-arm, 12-week pilot study evaluating the effects of a chickpea pasta on gut microbiome diversity, gastrointestinal health, and blood biomarkers. The study will involve 12 participants consuming the test product five times per week, with questionnaires, microbiome testing, blood testing, and waist measurements collected at defined timepoints.

Enrollment

12 patients

Sex

All

Ages

21 to 44 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Be male or female
Be aged 21-44.
Anyone currently experiencing issues regarding all of the following:
Struggling to balance taste with health and convenience.
Struggling to eat healthy due to a busy lifestyle.
Self-reported poor gut health (including bloating, abdominal discomfort, and gas).
Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
If taking oral over-the-counter supplements or herbal remedies targeted at gut health, blood sugar, and overall health and well-being, has been consistently taking these for at least 3 months prior to starting the study, and is willing to maintain this routine for the study duration.
Not planning on introducing any products or any new forms of prescription medication or supplements that target gut health, blood sugar, or overall health and well-being for the study duration.
Anyone willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.
Anyone who has tried pasta alternatives in the past (e.g., made of chickpeas, lentils, beans, etc.) or, if not, is open to trying them.
Anyone with access to a 3-quart pasta pot that can be used 5 times weekly.
Resides in the United States.
Not currently partaking in another research study and will not be partaking in any other research study for the next 12 weeks and at any point during this study's duration.

Exclusion criteria

Has been diagnosed with Type 1 or Type 2 diabetes.
Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
Anyone with known severe allergic reactions.
Anyone with any allergies or sensitivities to any of the study product ingredients.
Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
Anyone unwilling to follow the study protocol.
Anyone who has undergone any surgeries or invasive treatments in the last six months.
Anyone planning to undergo any surgeries or invasive treatments during the study period.
Anyone with a known history of severe digestive disorders like acid reflux, irritable bowel syndrome (IBS), irritable bowel disease (IBD), Crohn's disease, or gastrointestinal tract surgeries.
Anyone with a history of substance abuse.
Anyone who eats a pasta alternative (like chickpea pasta) one or more times per week.
Follows a specific diet, such as ketogenic, paleo, or gluten-free